Cargando…

Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab

Detalles Bibliográficos
Autores principales: Pampín-Sánchez, R, Barbazán-Vázquez, FJ, Fernández-González, B, Rodríguez-de-Castro, B, Aparicio-Carreño, C, Sampedro-Gimeno, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193621/
https://www.ncbi.nlm.nih.gov/pubmed/33779367
http://dx.doi.org/10.1177/10781552211004680
_version_ 1783706263621730304
author Pampín-Sánchez, R
Barbazán-Vázquez, FJ
Fernández-González, B
Rodríguez-de-Castro, B
Aparicio-Carreño, C
Sampedro-Gimeno, T
author_facet Pampín-Sánchez, R
Barbazán-Vázquez, FJ
Fernández-González, B
Rodríguez-de-Castro, B
Aparicio-Carreño, C
Sampedro-Gimeno, T
author_sort Pampín-Sánchez, R
collection PubMed
description
format Online
Article
Text
id pubmed-8193621
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-81936212021-06-28 Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab Pampín-Sánchez, R Barbazán-Vázquez, FJ Fernández-González, B Rodríguez-de-Castro, B Aparicio-Carreño, C Sampedro-Gimeno, T J Oncol Pharm Pract Letters to the Editor SAGE Publications 2021-03-27 2021-06 /pmc/articles/PMC8193621/ /pubmed/33779367 http://dx.doi.org/10.1177/10781552211004680 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Letters to the Editor
Pampín-Sánchez, R
Barbazán-Vázquez, FJ
Fernández-González, B
Rodríguez-de-Castro, B
Aparicio-Carreño, C
Sampedro-Gimeno, T
Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
title Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
title_full Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
title_fullStr Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
title_full_unstemmed Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
title_short Re: Long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
title_sort re: long-term control in a patient with metastatic lung adenocarcinoma after discontinuation of nivolumab
topic Letters to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8193621/
https://www.ncbi.nlm.nih.gov/pubmed/33779367
http://dx.doi.org/10.1177/10781552211004680
work_keys_str_mv AT pampinsanchezr relongtermcontrolinapatientwithmetastaticlungadenocarcinomaafterdiscontinuationofnivolumab
AT barbazanvazquezfj relongtermcontrolinapatientwithmetastaticlungadenocarcinomaafterdiscontinuationofnivolumab
AT fernandezgonzalezb relongtermcontrolinapatientwithmetastaticlungadenocarcinomaafterdiscontinuationofnivolumab
AT rodriguezdecastrob relongtermcontrolinapatientwithmetastaticlungadenocarcinomaafterdiscontinuationofnivolumab
AT apariciocarrenoc relongtermcontrolinapatientwithmetastaticlungadenocarcinomaafterdiscontinuationofnivolumab
AT sampedrogimenot relongtermcontrolinapatientwithmetastaticlungadenocarcinomaafterdiscontinuationofnivolumab